Analytical Data
-
Gene name
GHDC
- Application
-
Alternative Names
GHDC; D11LGP1E; LGP1; GH3 domain-containing protein
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N2G8
-
Expression Region
1-530aa
-
AA Sequence
MLLWPLLLLLLLLPTLALLRQQRSQDARLSWLAGLQHRVAWGALVWAATWQRRRLEQSTLHVHQSQQQALRWCLQGAQRPHCSLRRSTDISTFRNHLPLTKASQTQQEDSGEQPLPPTSNQDLGEASLQATLLGLAALNKAYPEVLAQGRTARVTLTSPWPRPLPWPGNTLGQVGTPGTKDPRALLLDALRSPGLRALEAGTAVELLDVFLGLETDGEELAGAIAAGNPGAPLRERAAELREALEQGPRGLALRLWPKLQVVVTLDAGGQAEAVAALGALWCQGLAFFSPAYAASGGVLGLNLQPEQPHGLYLLPPGAPFIELLPVKEGTQEEAASTLLLAEAQQGKEYELVLTDRASLTRCRLGDVVRVVGAYNQCPVVRFICRLDQTLSVRGEDIGEDLFSEALGRAVGQWAGAKLLDHGCVESSILDSSAGSAPHYEVFVALRGLRNLSEENRDKLDHCLQEASPRYKSLRFWGSVGPARVHLVGQGAFRALRAALAACPSSPFPPAMPRVLRHRHLAQCLQERVVS
-
Molecular Weight
83.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of GHDC (Glucose homeostasis and development control) recombinant proteins has emerged as a significant area of research due to their crucial role in metabolic regulation and developmental processes. GHDC proteins regulate glucose homeostasis, influencing insulin signaling pathways and metabolic disorders such as obesity and diabetes. The understanding of these proteins is critical as they hold promise for developing therapeutic strategies aimed at mitigating the effects of metabolic syndromes. Furthermore, recombinant technology enables the production of these proteins in a more efficient and controlled manner, facilitating detailed studies of their structure and function. By employing recombinant DNA technology, researchers can produce large quantities of GHDC proteins, allowing them to explore their biological activities and interactions in various cellular contexts. This understanding is not only vital for basic biological research but also for translational applications, including drug design and gene therapy. The investigation of GHDC recombinant proteins highlights their potential as biomarkers for metabolic diseases and opens avenues for targeted treatments in the field of endocrinology and metabolism. As a result, GHDC proteins stand at the forefront of metabolic research, merging the fields of molecular biology, biochemistry, and medicine to combat global health challenges related to metabolic disorders.
